🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Medical Payment Case Management for Financial Toxicity in Patients With Primary Bone Tumors: A Randomized Controlled Trial

RecruitingNAAges any - anyAllShanghai 6th People's Hospital
NCT07888244 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if adding a medical payment case management service to the hospital's usual follow-up care can reduce the financial hardship of cancer treatment in patients of any age, including children and teenagers, who have a primary bone tumor and are scheduled to have surgery at Shanghai Sixth People's Hospital. It will also learn whether the service lowers the number of families who spend a large share of their yearly income on medical care. The main questions it aims to answer are: Does the service improve patients' scores on a questionnaire that measures financial hardship (the COST-FACIT) from the start of the study to 6 months later? Does the service lower the number of families whose out-of-pocket medical costs reach 10% or more of the family's yearly income? The study will enroll 124 patients, randomly assigned in a 1:1 ratio to two groups of 62

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Histologically confirmed primary bone tumor, with surgery planned at Shanghai Sixth People's Hospital 2. Registered on the whole-course patient management program of the hospital's Comprehensive Oncology Center (COC) 3. Able to complete the study questionnaires, either independently or with assistance from a parent 4. Provision of informed consent and willingness to participate. For participants under 18 years of age, informed consent is provided by the legal guardian and the participant's own assent is also obtained Exclusion Criteria: 1. Secondary or metastatic bone tumor 2. Cognitive impairment or psychiatric illness that prevents completion of the questionnaires 3. Surgery is not the main treatment modality 4. Refusal to participate 5. Benign bone tumor, such as osteoma, osteoid osteoma, osteochondroma, enchondroma, periosteal chondroma, chondroblastoma, chondromyxoid fibroma, chondromesenchymal hamartoma of the chest wall, or notochordal rest hyperplasia / benign notochordal cell tumor
💊

What it tests

  • Medical payment case management service
📍

Where

1 site
Shanghai Sixth People's Hospital
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy